BREAKING
Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 20 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 21 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 22 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago Earnings Summary: A snapshot of Duke Energy’s Q4 2025 report 20 hours ago Fiserv (FISV) Earnings: 4Q25 Key Numbers 21 hours ago CVS Health (CVS) Q4 2025 revenue rises 8%; adjusted earnings decline 22 hours ago Chegg Q4 2025 Earnings Soar: New Strategy Stuns Market 1 day ago PAL Q4 2025 Earnings Explode: Mergers Pay Off Now 1 day ago Outdoor Holding Company Q3 2026 Earnings Soar 7% 2 days ago Apollo Q4 2025 Earnings Rocket: Historic AUM Breakthrough 2 days ago Anavex Q1 2026 Earnings Rise: Breakthrough Drug Nears 2 days ago Dynatrace Shares Rise After Q3 Fiscal 2026 Results Beat Guidance 2 days ago Eli Lilly and Company (LLY) to acquire Orna Therapeutics 2 days ago
ADVERTISEMENT
AlphaGraphs

Chewy (CHWY) earnings preview: Q3 might set the stage for turnaround

Chewy Inc. (NYSE: CHWY) has lost significant market value ever since the online pet food company made its stock market debut earlier this year, raising about $1 billion. There is apprehension about the stock’s future, while the company prepares for its third-quarter earnings release, which is scheduled for December 9 after the closing bell. Chewy […]

$CHWY December 5, 2019 2 min read

Chewy Inc. (NYSE: CHWY) has lost significant market value ever since the online pet food company made its stock market debut earlier this year, raising about $1 billion. There is apprehension about the stock’s future, while the company prepares for its third-quarter earnings release, which is scheduled for December 9 after the closing bell.

Chewy is expected to report a loss of $0.16 per share for the October-quarter, on revenues of $1.2 billion. The forecast is broadly in line with the management’s prediction for the period.

Chewy (CHWY) Q2 sales surge

The market will be closely following the event, looking for updates on the prospects of the company turning profitable in the near term. Encouragingly, the management’s branding initiatives and efforts to ramp up the online platform seem to have positively influenced performance in the second half, and the trend is expected to continue in the coming months.  

Growth Drivers

The roll-out of fulfillment centers and augmentation of delivery services should add to sales growth in the third quarter. Also, the market’s response to the recently launched Chewy Pharmacy has been positive. There is no doubt it is a promising venture, considering the growing awareness about pet-wellbeing.

Like in the case of all emerging start-ups, Chewy’s margins remain under pressure from high selling and administrative expenses, though its impact on the bottom line is expected to be lighter this time compared to the previous quarters.   

ADVERTISEMENT

Loss Widens

In the second quarter, sales surged 43% annually to $1.15 billion and exceeded the consensus forecast, reflecting a sharp increase in the number of active customers to 12 million. However, the company posted a wider loss of $0.21 per share that missed the estimates.

Upgrade

Chewy got a major boost Thursday after Morgan Stanley (MS) upgraded its rating on the stock to Overweight, citing favorable market conditions for the business that might help the company double its sales in the next five years.

Since the mixed Wall Street debut around six months ago, the stock declined steadily and hit an all-time low last month. The value dropped 34% so far and traded below the $25-mark this week.

Browse through our earnings calendar and get all scheduled earnings announcements, analyst/investor conference and much more!

ADVERTISEMENT